Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TUSC3 |
| Upstream (Parents) |
|---|
| (<<) EML1 → TUSC3 |
| (<<) HEG1 → TUSC3 |
| (<<) TCF4 → TUSC3 |
| (<<) CAV1 → TUSC3 |
| Downstream (Children) |
|---|
| TUSC3 → EML1 (>>) |
| TUSC3 → PLXND1 (>>) |
| TUSC3 → WWTR1 (>>) |
| TUSC3 → FSCN1 (>>) |
| TUSC3 → C12orf39 (>>) |
| TUSC3 → ZNF500 (>>) |
| TUSC3 → ACRV1 (>>) |
| TUSC3 → RPS6KA2 (>>) |
| TUSC3 → PGLYRP4 (>>) |
| TUSC3 → PSMD4 (>>) |
| TUSC3 → GJA3 (>>) |
| TUSC3 → SLC10A2 (>>) |
| TUSC3 → LMO4 (>>) |
| TUSC3 → SRD5A3 (>>) |
| TUSC3 → WDR91 (>>) |
| TUSC3 → LIMCH1 (>>) |
| TUSC3 → NPFFR1 (>>) |
| TUSC3 → NRXN1 (>>) |
| TUSC3 → EPHA5 (>>) |
| TUSC3 → HIST1H3I (>>) |
| TUSC3 → PMS2L4 (>>) |
| TUSC3 → TUBB1 (>>) |
| TUSC3 → ETV1 (>>) |
| TUSC3 → AKAP4 (>>) |
| TUSC3 → PRTN3 (>>) |
| TUSC3 → YBX2 (>>) |
| TUSC3 → B3GALNT1 (>>) |
| TUSC3 → SCG5 (>>) |
